The ongoing legal battle of a former marketing director at Santé Ventures, Youngjoo Rhee, takes another twist as she faces a decision regarding her $1.4 million jury verdict. Rhee, who has already undergone two jury trials related to her bonus payments, is now asked by a federal judge to either accept a reduced award or prepare for a third trial. The verdict awarded by the jury does not accurately reflect a $300,000 reduction previously agreed upon, according to Judge Lewis J. Liman.
The judge has indicated that the evidence presented during the trial supports a maximum payout of $1.2 million. This amount constitutes two bonuses valued at $750,000 each, offset by the $300,000 that had already been paid to Rhee. The discrepancy in the jury’s decision, which appears not to account for this reduction, remains the crux of this legal impasse.
This case highlights the complexities involved in legal disputes regarding compensation, especially in high-stakes corporate environments such as hedge funds like Santé Ventures. The decision awaiting Rhee will not only impact her potential payout but also sheds light on the intricate dynamics between jury verdicts and judicial reviews. For more details on this development, visit the original report by Bloomberg Law.